Caplight Directory>Companies>Slate Medicines-preview>Slatemedicines


Slate Medicines

Slate Medicines

Private
Raleigh, North CarolinaHealthcare & Life Scienceshttps://www.slatemedicines.com/

Last Round

Series A

Feb 24, 2026

Total Funding Raised

$130M

Company Overview

Slate Medicines is a biotechnology company developing next-generation therapeutics for migraine and other headache disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

anti-PACAP antibodymigraine preventionPACAP pathwaymonoclonal antibodymigraine therapeuticsmAb therapybiologic therapyclinical-stage biotechheadache disorder treatmentCGRP alternativesubcutaneous administrationdrug developmentneurology therapeuticshalf-life extension

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Slate Medicines Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Slate Medicines Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 24, 2026
View all Funding Rounds

Slate Medicines Investors

Notable investors and investment history

InvestorRounds
Forbion Capital PartnersSeries A
RA Capital ManagementSeries A
Foresite CapitalSeries A
View all Investors

Slate Medicines Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Slate Medicines Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Slate Medicines's valuation, stock price, and market status.

Firmographic Details

HeadquartersRaleigh, North Carolina
Year Founded2026
Last FundingFeb 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.